Phase 1 clinical trial of CCT-217
Latest Information Update: 20 Jan 2025
Price :
$35 *
At a glance
- Drugs CCT 217 (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacokinetics
- 10 Jan 2025 According to Canary Cure media release, company to begin Phase 1 clinical trials in 2026.
- 10 Dec 2024 New trial record